Fitch revises outlook on Jubilant Pharma to negative; affirms at 'BB'
Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).
Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).
The vaccine will be priced at Rs. 265 per dose and the applicator being offered at Rs. 93 per dose excluding GST
The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct
Avra Labs is a Hyderabad based contract manufacturing and research services (CRAMs) and specialty active pharmaceutical ingredients (API) manufacturer with four facilities across the states of Telangana and Andhra Pradesh
The stability is led by healthy demand in the domestic and emerging markets
Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation
The transaction is expected to close in the first quarter of 2022
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
The transaction is anticipated to close in the first quarter of 2022
Subscribe To Our Newsletter & Stay Updated